4.7 Article

Endoscopic therapy of small-bowel polyps by double-balloon enteroscopy in patients with Peutz-Jeghers syndrome

Journal

GASTROINTESTINAL ENDOSCOPY
Volume 71, Issue 4, Pages 768-773

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.gie.2009.11.005

Keywords

-

Ask authors/readers for more resources

Background: Peutz-Jeghers syndrome (PJS) is a hereditary disorder characterized by mucocutaneous pigmentations and hamartomatous polyps mainly in the small bowel. These polyps may cause complications such as intussusception. Objective: To assess therapeutic efficacy and safety of double-balloon enteroscopy (DBE) for detection and treatment of small-bowel polyps in patients with PIS. Design: Prospective cohort study. Setting: Tertiary-care referral center. Patients: This study involved 13 patients with PIS, defined as a proven STK11 gene mutation or according to international diagnostic criteria. Intervention: DBE with enteroscopic removal of pedunculated polyps of >= 10 mm. Main Outcome Measurements: Location, number and size of small-bowel polyps, polypectomy data, and complications and long-term complications associated with development of small-intestine polyps. Results: Thirteen patients with PJS (8 male, mean age 31 years) underwent 29 DBE procedures. Ten patients (77%) had a history of partial small-bowel resection because of small-bowel polyps. Small-bowel polyps were found in all 13 patients. The majority of polyps (94%) were located in the proximal jejunum. A total of 82 polyps of >= 10 mm were detected, and 79 (96%) were endoscopically removed without complications. After the introduction of DBE, no small-intestine-polyp-related complications occurred during a follow-up period of 356 person-months. Limitations: Small number of patients Conclusion: DBE is clinically useful and safe for diagnosis and therapy of small-bowel polyps in patients with PIS, even in patients with a history of extensive abdominal surgery. DBE may decrease the need for laparotomy in patients with PIS. (Gastrointest Endosc 2010.71:768-73.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis

Hao Dang, Nik Dekkers, Saskia le Cessie, Jeanin E. van Hooft, Monique E. van Leerdam, Philip P. Oldenburg, Louis Flothuis, Jan W. Schoones, Alexandra M. J. Langers, James C. H. Hardwick, Jolein van der Kraan, Jurjen J. Boonstra

Summary: The cumulative incidence of colorectal cancer recurrence for patients with T1 CRC treated with local endoscopic resection only is 3.3%, with the majority of recurrences occurring within 72 months of follow-up.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Universal Immunohistochemistry for Lynch Syndrome: A Systematic Review and Meta-analysis of 58,580 Colorectal Carcinomas

Ellis L. Eikenboom, Anne-Sophie van der Werf-'t Lam, Mar Rodriguez-Girondo, Christi J. Van Asperen, Winand N. M. Dinjens, Robert M. W. Hofstra, Monique E. Van Leerdam, Hans Morreau, Manon C. W. Spaander, Anja Wagner, Maartje Nielsen

Summary: This study investigates the effectiveness and cost of immunohistochemistry testing in Lynch syndrome patients and their relatives. The proportion of MMRd and MMR germline PV is influenced by age, completeness, and type of diagnostics, and complete diagnostics can explain almost all MMRd CRC, contributing to optimizing testing and surveillance.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors

Berbel L. M. Ykema, Lisanne S. Rigter, Manon C. W. Spaander, Leon M. G. Moons, Tanya M. Bisseling, Berthe M. P. Aleman, Evelien Dekker, Wieke H. M. Verbeek, Ernst J. Kuipers, Jan Paul de Boer, Pieternella J. Lugtenburg, Cecile P. M. Janus, Eefke J. Petersen, Judith M. Roesink, Richard W. M. van der Maazen, Gerrit A. Meijer, Michael Schaapveld, Flora E. van Leeuwen, Beatriz Carvalho, Petur Snaebjornsson, Monique E. van Leerdam

Summary: The study evaluated clinicopathological characteristics and risk factors for developing (advanced) neoplasia (AN) in Hodgkin's lymphoma (HL) survivors who had undergone abdominal radiotherapy and/or procarbazine treatment. Colorectal neoplasia in HL survivors differs from average-risk controls, with AN primarily classified based on polyp size (>=10 mm) and longer follow-up between HL diagnosis and colonoscopy associated with a higher prevalence of AN.

DIGESTIVE ENDOSCOPY (2022)

Article Surgery

The Detrimental Impact of the COVID-19 Pandemic on Major Trauma Outcomes in the Netherlands A Comprehensive Nationwide Study

Mitchell L. S. Driessen, Leontien M. Sturms, Frank W. Bloemers, Henk Jan ten Duis, Michael J. R. Edwards, Dennis den Hartog, E. J. Kuipers, Peter A. Leenhouts, Martijn Poeze, Inger B. Schipper, Richard W. Spanjersberg, Klaus W. Wendt, Ralph J. de Wit, Stefan W. A. M. van Zutphen, Mariska A. C. de Jongh, Luke P. H. Leenen

Summary: The COVID-19 pandemic has had an adverse effect on the outcome of major trauma patients in the Netherlands. Fewer patients, especially those with less severe traumatic brain injuries, were admitted to the ICU during the peak period, resulting in increased mortality rates for this subgroup.

ANNALS OF SURGERY (2022)

Article Oncology

A population-based linked cohort of cancer and primary care data: A new source to study the management of cancer in primary care

Josephina G. Kuiper, Myrthe P. P. Van Herk-Sukel, Valery E. P. P. Lemmens, Ernst J. Kuipers, Ron M. C. Herings

Summary: The NCR-PHARMO GP cohort, consisting of 135,868 cancer patients, provides rich data on primary care management of cancer, enabling large-scale observational cancer research in the primary care setting. Patient-level linkage allows for long-term follow-up with ongoing annual updates.

EUROPEAN JOURNAL OF CANCER CARE (2022)

Article Oncology

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)

S. A. Nieuwenburg, M. C. Mommersteeg, L. M. M. Wolters, A. J. van Vuuren, N. Erler, M. P. Peppelenbosch, G. M. Fuhler, M. J. Bruno, E. J. Kuipers, M. C. W. Spaander

Summary: This study found that FIT can be used with high accuracy and sensitivity for the diagnosis of H. pylori, and is considered the most convenient test method. Non-invasive Hp-FIT test shows great promise for combined upper and lower gastrointestinal (pre-) cancerous screening. Further research should explore the clinical implications, benefits, and cost-effectiveness of this approach.

GASTRIC CANCER (2022)

Article Gastroenterology & Hepatology

Toll-Like Receptor 1 Locus Re-examined in a Genome-Wide Association Study Update on Anti-Helicobacter pylori IgG Titers

Suk Yee Lam, Michiel C. Mommersteeg, Bingting Yu, Linda Broer, Manon C. W. Spaander, Fabian Frost, Stefan Weiss, Henry Voelzke, Markus M. Lerch, Ben Schoettker, Yan Zhang, Hannah Stocker, Hermann Brenner, Daniel Levy, Shih-Jen Hwang, Alexis C. Wood, Stephen S. Rich, Jerome I. Rotter, Kent D. Taylor, Russell P. Tracy, Edmond K. Kabagambe, Marcis Leja, Janis Klovins, Raitis Peculis, Dace Rudzite, Liene Nikitina-Zake, Girts Skenders, Vita Rovite, Andre Uitterlinden, Ernst J. Kuipers, Gwenny M. Fuhler, Georg Homuth, Maikel P. Peppelenbosch

Summary: The association between anti-H pylori IgG titers and the TLR1/6/10 locus was not replicated across different populations, and the variation at this locus affected TLR1-mediated cytokine production and TLR1 surface expression on monocytes and neutrophils.

GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Use of topical mineral powder as monotherapy for treatment of active peptic ulcer bleeding

Joseph J. Y. Sung, Sulleman Moreea, Harinder Dhaliwal, Dana C. Moffatt, Krish Ragunath, Terry Ponich, Alan N. Barkun, Ernst J. Kuipers, Robert Bailey, Fergal Donnellan, David Wagner, Keith Sanborn, James Lau

Summary: The study evaluated the safety and effectiveness of Hemospray as a monotherapy for active peptic ulcer bleeding. Results showed that Hemospray was successfully administered in nearly all patients, with a high rate of hemostasis achieved. Recurrent bleeding was observed in a small percentage of patients, but no adverse events were attributed to the use of Hemospray.

GASTROINTESTINAL ENDOSCOPY (2022)

Article Oncology

Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands

Emilie C. H. Breekveldt, Esther Toes-Zoutendijk, Manon C. W. Spaander, Hilliene J. van de Schootbrugge-Vandermeer, Anneke J. van Vuuren, Folkert J. van Kemenade, Christian R. B. Ramakers, Evelien Dekker, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar

Summary: The Dutch colorectal cancer (CRC) screening programme based on faecal immunochemical testing has shown a decrease in advanced-stage CRC incidence after its introduction in 2014. The incidence initially increased before screening but later decreased and remained below expected levels. These findings provide evidence for the effectiveness of the Dutch screening programme in reducing advanced-stage CRC incidence.

EUROPEAN JOURNAL OF CANCER (2023)

Article Oncology

Prevalence of Sarcopenia and Impact on Survival in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours

Dominique S. V. M. Clement, Monique E. van Leerdam, Soraya de Jong, Martin O. Weickert, John K. Ramage, Margot E. T. Tesselaar, Rajaventhan Srirajaskanthan

Summary: Neuroendocrine tumours (NETs) are rare tumours arising in the digestive system, mainly the small bowel or pancreas. This study aimed to describe the presence of sarcopenia at the time of diagnosis of stage IV NET in the digestive system and correlate it with survival. Sarcopenia was present in 69% of patients, and its presence in pancreatic NETs was associated with poorer survival.

CANCERS (2023)

Article Gastroenterology & Hepatology

Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis

Esther Toes-Zoutendijk, Lucie de Jonge, Carola Adriana van Iersel, Manon C. W. Spaander, Anneke J. van Vuuren, Folkert van Kemenade, Christian R. Ramakers, Evelien Dekker, Iris D. Nagetaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar

Summary: The study assessed the impact of delayed invitation on screen-detected and interval colorectal cancers (CRC) in a FIT-based CRC screening program. Individual-level data from individuals who participated in 2017 and 2018 with a negative FIT and were eligible for screening in 2019 and 2020 were analyzed. The results showed that the first COVID-19 wave had a modest impact on screening yield, and a small proportion of FIT negatives had interval CRC, possibly due to an extended invitation interval.
Review Surgery

Defining near-complete response following (chemo)radiotherapy for rectal cancer: systematic review

Petra A. Custers, Barbara M. Geubels, Geerard L. Beets, Doenja M. J. Lambregts, Monique E. van Leerdam, Baukelien van Triest, Monique Maas

Summary: This review identified the heterogeneity in terminology, criteria, and features used to define a near-complete response. The differences may be related to therapeutic aims and strategies. A reproducible definition of near-complete response is necessary.

BRITISH JOURNAL OF SURGERY (2022)

Meeting Abstract Gastroenterology & Hepatology

ADENOMA DETECTION RATE AND RISK OF INTERVAL POST-COLONOSCOPY COLORECTAL CANCER IN FIT-BASED SCREENING

Pieter Wisse, Nicole S. Erler, S. Y. D. Boer, Gijsbert Den Hartog, M. Oudkerk Pool, Jochim S. Terhaar Sive Droste, C. Verveer, Gerrit Meijer, Iris Lansdorp-Vogelaar, Ernst J. Kuipers, Evelien Dekker, Manon Spaander

GASTROINTESTINAL ENDOSCOPY (2022)

Article Oncology

First-Line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial

Sonja Levy, Wieke H. M. Verbeek, Ferry A. L. M. Eskens, Jose G. van den Berg, Derk Jan A. de Groot, Monique E. van Leerdam, Margot E. T. Tesselaar

Summary: The study demonstrates that the combination of everolimus and cisplatin is an effective treatment option for advanced EP-NEC, especially in carefully selected patients. The treatment resulted in high disease control rate and overall response rate, with some patients experiencing durable responses.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

No Data Available